Pleiotropic Effects of YC-1 Selectively Inhibit Pathological Retinal Neovascularization and Promote Physiological Revascularization in a Mouse Model of Oxygen-Induced Retinopathy-Reference-Cited by-同舟云学术

Pleiotropic Effects of YC-1 Selectively Inhibit Pathological Retinal Neovascularization and Promote Physiological Revascularization in a Mouse Model of Oxygen-Induced Retinopathy

Published:2009-12-14 Issue:3 Volume:77 Page:348-367
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

DeNiro M.,Al-Halafi A.,Al-Mohanna F. H.,Alsmadi O.,Al-Mohanna F. A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference95 articles.

1. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes

2. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders;Abu el-Asrar;Am J Ophthalmol,1997

3. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia;Adachi;Graefes Arch Clin Exp Ophthalmol,1998

4. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

5. An international classification of retinopathy of prematurity;Anonymous;Pediatrics,1984

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Applications and Mechanisms of YC-1: A Soluble Guanylate Cyclase Stimulator;Vascular Biology - Selection of Mechanisms and Clinical Applications;2020-11-11

2. An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization;Proceedings of the National Academy of Sciences;2020-10-26

3. Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity;International Journal of Molecular Sciences;2019-09-03

4. Müller cells in pathological retinal angiogenesis;Translational Research;2019-05

5. Pharmacologic Targeting of Hypoxia-Inducible Factors;Annual Review of Pharmacology and Toxicology;2019-01-06